Pancreatic cancer is one of the lethal types of cancer due to its ability to metastasize throughout the body. Despite recent advances in pancreatic cancer research, all the current cancer therapies have severe limitations in treating metastatic pancreatic cancer. Therefore, there is a need for a treatment regimen that can both break the immunosuppressive nature of the tumor and control cancer metastasis. We used a novel localized ablative immunotherapy, a combination of interstitial photothermal therapy (iPTT) and intratumoral administration of immunostimulant, to treat pancreatic tumors in mouse model. Here, we investigated the effects of iPTT on the tumor microenvironment or orthotopic mouse model to determine the optimal ablative effects. This treatment regimen will later be combined with an immunostimulant for a synergistic approach to provide an effective treatment modality for metastatic pancreatic cancers.
|